Pterostilbene significantly inhibited DMBA/TPA-induced skin tumor formation via suppressing activation of NF-κB, AP-1, ERK1/2, JNK1/2, and PI3K/Akt. The gene discussed is MAPK3; the disease is skin neoplasm.